AI Healthcare Market — $110.6B by 2030

The global AI in healthcare market is projected to reach approximately $110.6 billion by 2030, up from $22.5 billion in 2023 — a compound annual growth rate in the high-30% range.

These numbers come from published market-research reports (Grand View Research, MarketsandMarkets, Precedence Research, among others). They converge on a similar trajectory even when individual methodology differs, which suggests the underlying trend is robust — even if any single point estimate should be treated with the usual skepticism applied to multi-year market projections.

Composition of the projected spend:

• Diagnostics — largest segment, imaging-AI software and workflow tools.
• Drug discovery — rapid growth segment, driven by AlphaFold-era structural biology tools and generative-chemistry platforms.
• Administrative and operational — revenue-cycle AI, clinical-documentation assistants, staffing optimization. Often overlooked but commercially significant.
• Clinical decision support — smaller by dollar, high by strategic weight because of clinical-workflow integration.
• Remote monitoring, wearables, digital therapeutics — projected high growth but sensitive to reimbursement policy.

The gap between market projection and clinical-deployment reality is the single biggest question for capital allocation. Market size grows regardless of whether AI delivers outcomes; deployed value grows only where specific workflows integrate AI with measurable benefit.

For innovators: the projection does not mean “build AI, customers will come.” It means serious capital is chasing the category. Competitive intensity, not demand shortage, is the binding constraint for new entrants.